Gamaleya Center to Submit Documents for Testing COVID Vaccine Platforms

National Research Center for Epidemiology and Microbiology named after N.F. Gamalei is submitting documents to test new platforms for vaccines against the following mutations of the coronavirus. This was announced by the director of the Gamaleya Center Alexander Gintsburg, TASS reports.

“In order to protect against the next possible mutations, we are preparing new platforms that will contain antigenic variants for several variants of the coronavirus. Now the submission of documents for obtaining a permit for testing is already beginning, ”Gintsburg said.

On January 16, Denis Logunov, deputy head of the Gamaleya Center, said that their specialists are considering the possibility of developing a coronavirus vaccine based on several strains, such as Delta and Omicron.

“It is being considered and discussed how to make a polyvalent “Sputnik”, where there will be both “delta” and “omicron”, in order to cover the base layers - “wuhan” or “delta”, from where a new sprout of a new strain that causes alertness can come from, - he said. According to him, "omicron" will "close these sprouts" as it also evolves.

According to the latest data from the operational headquarters, over the past day in Russia, the number of people infected with coronavirus has reached 113,122 people, 668 people have died. For the entire period of the pandemic in the country, 11,615,779 Russians fell ill with COVID-19 , 330,111 people died.